Drug Shortage Report for TEVA-PAROXETINE

Last updated on 2025-01-23 History
Report ID 100553
Drug Identification Number 02248557
Brand name TEVA-PAROXETINE
Common or Proper name PAROXETINE 20MG TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PAROXETINE
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2022-12-09
Estimated end date
Actual end date 2025-01-20
Shortage status Resolved
Updated date 2025-01-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-01-23 French Compare
v8 2025-01-23 English Compare
v7 2022-08-18 French Compare
v6 2022-08-18 English Compare
v5 2022-01-20 French Compare
v4 2022-01-20 English Compare
v3 2019-12-10 English Compare
v2 2019-12-09 French Compare
v1 2019-12-09 English Compare

Showing 1 to 9 of 9